Vitamin C Deficiency Diagnosis and Treatment

Diagnostic Approach

• The American College of Nutrition recommends diagnosing vitamin C deficiency clinically based on characteristic symptoms, and not delaying treatment while awaiting laboratory confirmation if clinical features are present 1
• Mucocutaneous bleeding, such as petechiae, ecchymoses, bleeding gums, and gingival swelling, are diagnostic features of vitamin C deficiency 1

Laboratory Testing Considerations

• The National Institute of Nutrition recommends plasma vitamin C measurement as the preferred diagnostic test when laboratory confirmation is needed 2
• Plasma levels are unreliable during inflammation, with vitamin C levels declining when CRP >10 mg/L, and normal values not detected if CRP >40 mg/L 2, 3
• Testing is only recommended for suspected scurvy or chronic low intake, and not during acute inflammation or critical illness 1

High-Risk Populations to Screen

• The American Society for Nutrition recommends screening patients on chronic dialysis, critical illness, major surgery, and post-bariatric surgery for vitamin C deficiency 2, 3

Treatment Protocol

• The American College of Nutrition recommends initiating oral vitamin C 100 mg three times daily (300-500 mg/day total) for at least one month for symptomatic deficiency 1
• Alternative regimens include 250 mg twice daily for 3 weeks for clinical scurvy, and single daily dosing of 500 mg once daily for 1 month 1
• Oral administration is standard for uncomplicated deficiency, while IM, IV, or subcutaneous routes are used when malabsorption is suspected 3

Special Clinical Scenarios Requiring Higher Doses

• Critically ill patients during acute inflammation require 2-3 g/day IV vitamin C 2, 1
• Patients undergoing continuous renal replacement therapy require 2-3 g/day IV vitamin C 2, 1
• Cardiac surgery patients require 1-2 g/day IV vitamin C for 5-7 days perioperatively 3, 1

Maintenance After Repletion

• Healthy adults require 75-90 mg/day of vitamin C, achievable with one medium-sized orange 1
• High-risk populations require continued supplementation of 200-500 mg/day indefinitely 1

Critical Safety Considerations

• Contraindications to high-dose vitamin C (>1 g/day) include hemochromatosis, G6PD deficiency, active oxalate kidney stones, and severe renal dysfunction 4

Common Pitfalls to Avoid

• Vitamin C levels should not be measured in acutely ill or inflamed patients, as results will be falsely low and misleading 2, 3
• Vitamin C should not be used as routine pharmacotherapy for sepsis, as current evidence does not support this practice 4

Treatment of Scurvy in Special Populations

Pediatric Dosing

• The American Academy of Pediatrics recommends preterm and term infants up to 12 months to receive 15-25 mg/kg/day of vitamin C, and older children to receive 80 mg/day 5, 6

Maintenance Therapy

• The National Institutes of Health suggests that high-risk populations, including post-bariatric surgery patients, those with chronic oxidative stress, alcoholism, severe psychiatric illness, or poor dietary habits, should receive 200-500 mg/day of vitamin C indefinitely 5, 6

Evidence‑Based Management of Vitamin C Deficiency

Diagnostic Testing

• Plasma vitamin C measurement is the preferred laboratory test, but its results become unreliable when systemic inflammation is present; interpretation is difficult if C‑reactive protein (CRP) exceeds 10 mg/L and normal values may be undetectable when CRP is >40 mg/L. 7

Repletion Strategies for Uncomplicated Deficiency

• The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends oral repletion doses of 200–500 mg/day for patients with chronic malabsorption or increased oxidative stress. 7

Parenteral Administration in Malabsorptive Conditions

• Switch to intramuscular, intravenous, or sub‑cutaneous vitamin C when malabsorption is suspected (e.g., inflammatory bowel disease, post‑bariatric surgery, severe malnutrition). 7
• For intravenous infusion, dilute vitamin C in normal saline or dextrose solutions to minimise infusion‑related adverse reactions. 7

Maintenance Therapy for High‑Risk Populations

• After repletion, high‑risk groups—including individuals post‑bariatric surgery, those with chronic oxidative‑stress conditions such as diabetes, heart failure, smoking, alcoholism, severe chronic obstructive pulmonary disease, and chronic dialysis—should continue vitamin C at 200–500 mg/day indefinitely. 7

High‑Dose Intravenous Vitamin C in Critical Illness

• During the acute phase of critical illness, administer 2–3 g/day intravenously (Grade B recommendation, 84 % expert consensus). 7
• In sepsis and severe sepsis, some protocols use up to 200 mg/kg/day for 4 days. 7

Peri‑operative Vitamin C for Cardiac Surgery

• Provide 1–2 g/day intravenously for 5–7 days surrounding cardiac surgery (Grade 1+ recommendation). 7

Evidence‑Based Guidelines for Vitamin C Deficiency Diagnosis and Risk Assessment

Clinical Diagnosis

• In patients who exhibit the characteristic mucocutaneous findings of petechiae, gingival bleeding, perifollicular hemorrhages, corkscrew hairs, fatigue, arthralgia, and impaired wound healing, these signs alone are sufficient to establish a diagnosis of scurvy and to start vitamin C therapy without awaiting laboratory confirmation. 8

High‑Risk Populations

• Individuals receiving chronic dialysis are at increased risk for vitamin C deficiency because the dialysis process removes water‑soluble vitamins, including vitamin C. 8

Dietary Assessment

• When daily vitamin C intake drops below roughly 40–45 mg per day, scurvy can develop within 8–12 weeks in otherwise healthy adults. 9